Page last updated: 2024-11-02

piribedil and Restless Leg Syndrome

piribedil has been researched along with Restless Leg Syndrome in 2 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Research Excerpts

ExcerptRelevanceReference
"Thirteen consecutive patients with restless legs syndrome (RLS) were treated with piribedil and were rated using an RLS rating scale (0-10) and subjective response (0-100%); 11/13 (85%) had improvement of their mean RLS scores with subjective response ranging from 30% to 100% (mean 74."9.09Piribedil for restless legs syndrome: a pilot study. ( Evidente, VG, 2001)
"Thirteen consecutive patients with restless legs syndrome (RLS) were treated with piribedil and were rated using an RLS rating scale (0-10) and subjective response (0-100%); 11/13 (85%) had improvement of their mean RLS scores with subjective response ranging from 30% to 100% (mean 74."5.09Piribedil for restless legs syndrome: a pilot study. ( Evidente, VG, 2001)
"Sixteen patients with symptoms of restless legs syndrome and resulting insomnia are included in this study."2.66Restless legs syndrome treatment with dopaminergic drugs. ( Akpinar, S, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evidente, VG1
Akpinar, S1

Trials

2 trials available for piribedil and Restless Leg Syndrome

ArticleYear
Piribedil for restless legs syndrome: a pilot study.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans;

2001
Restless legs syndrome treatment with dopaminergic drugs.
    Clinical neuropharmacology, 1987, Volume: 10, Issue:1

    Topics: Adult; Aged; Benserazide; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Huma

1987